RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vanda Pharmaceuticals Stock

Vanda Pharmaceuticals ROA 2025

Vanda Pharmaceuticals ROA

0

Ticker

VNDA

ISIN

US9216591084

WKN

A0JJT3

In 2025, Vanda Pharmaceuticals's return on assets (ROA) was 0, a -61.05% increase from the 0.01 ROA in the previous year.

Vanda Pharmaceuticals Aktienanalyse

What does Vanda Pharmaceuticals do?

Vanda Pharmaceuticals Inc is a US biotechnology company specializing in the development and marketing of innovative therapies for neurological, psychiatric, and cardiovascular diseases. It was founded in 2002 by Mihael H. Polymeropoulos, who previously worked as a senior researcher at the genetic research company Novartis. Vanda Pharmaceuticals is based in Washington D.C. The company's business model focuses on developing and bringing to market medicines for rare diseases. It collaborates closely with clinics and research institutes to tailor innovative therapies and medications to the specific needs of patients. Vanda Pharmaceuticals operates in various areas, including neurology, psychiatry, and cardiology. In neurology, the company focuses on researching and developing therapies for rare diseases such as isolated sleeplessness syndrome and delayed sleep phase syndrome. In psychiatry, Vanda Pharmaceuticals has brought several medications to market for the treatment of schizophrenia, bipolar disorder, and depression. The medication Fanapt, in particular, has become a successful schizophrenia medication and has already been approved by the US FDA. In cardiology, Vanda Pharmaceuticals is working on the development of medications for the treatment of cardiovascular diseases such as heart failure and high blood pressure. One of Vanda Pharmaceuticals' most innovative therapy forms is chronotherapy, which involves timing the intake of certain medications to the body's natural circadian rhythm. The goal of chronotherapy is to maximize treatment effectiveness while minimizing side effects. An example of Vanda Pharmaceuticals' successes is the aforementioned medication Fanapt, which was approved by the FDA in 2009 and is distributed worldwide. Clinical studies have shown that Fanapt is safe and effective in the treatment of schizophrenia. The high expectations for the medication have led to Vanda Pharmaceuticals' listing on the NASDAQ and the company having a market value of several hundred million dollars. In conclusion, Vanda Pharmaceuticals is an innovative biotechnology company specializing in the research and development of therapies for rare diseases. With the successful introduction of medications like Fanapt, the company has established itself as an important player in the American and international markets. Vanda Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Vanda Pharmaceuticals's Return on Assets (ROA)

Vanda Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Vanda Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Vanda Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Vanda Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Vanda Pharmaceuticals stock

What is the Return on Assets (ROA) of Vanda Pharmaceuticals this year?

The Return on Assets (ROA) of Vanda Pharmaceuticals is 0 undefined this year.

What was the ROA of Vanda Pharmaceuticals compared to the previous year?

The ROA of Vanda Pharmaceuticals has increased by -61.05% compared to the previous year.

What consequences do high ROA have for investors of Vanda Pharmaceuticals?

A high ROA is advantageous for investors of Vanda Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Vanda Pharmaceuticals?

A low ROA can be unfavorable for investors of Vanda Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Vanda Pharmaceuticals affect the company?

An increase in ROA of Vanda Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Vanda Pharmaceuticals impact the company?

A reduction in the ROA of Vanda Pharmaceuticals can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Vanda Pharmaceuticals?

Some factors that can influence the ROA of Vanda Pharmaceuticals include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Vanda Pharmaceuticals important for investors?

The ROA of Vanda Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Vanda Pharmaceuticals take to improve ROA?

To improve ROA, Vanda Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Vanda Pharmaceuticals pay?

Over the past 12 months, Vanda Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vanda Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Vanda Pharmaceuticals?

The current dividend yield of Vanda Pharmaceuticals is .

When does Vanda Pharmaceuticals pay dividends?

Vanda Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vanda Pharmaceuticals?

Vanda Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Vanda Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vanda Pharmaceuticals located?

Vanda Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vanda Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vanda Pharmaceuticals from 2/10/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/10/2025.

When did Vanda Pharmaceuticals pay the last dividend?

The last dividend was paid out on 2/10/2025.

What was the dividend of Vanda Pharmaceuticals in the year 2024?

In the year 2024, Vanda Pharmaceuticals distributed 0 USD as dividends.

In which currency does Vanda Pharmaceuticals pay out the dividend?

The dividends of Vanda Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Vanda Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Vanda Pharmaceuticals

Our stock analysis for Vanda Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vanda Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.